Skip to content

Clinical trials

Completed Phase 1 Narcolepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Phase 1 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20142
20181
20191
20201
20211
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Vallon Pharmaceuticals, Inc.2
Axsome Therapeutics, Inc.1
Concert Pharmaceuticals1
Eisai Inc.1
Harmony Biosciences Management, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Takeda1
Teva Branded Pharmaceutical Products R&D, Inc.1
UCB Pharma SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy12
Attention Deficit Disorder with Hyperactivity2
Disorders of Excessive Somnolence2
Sleep Apnea, Obstructive1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.